-
Working with Moderna to see make its COVID vaccine available in India: Govt
expresspharma
July 12, 2021
The government said that it is working actively with COVID-19 vaccine manufacturer Moderna to see how its vaccine can be imported and made available in the country.
-
Israel offers Pfizer COVID-19 vaccine booster shots to adults at risk
firstwordpharma
July 12, 2021
Israel said on Sunday it will start offering a booster of Pfizer COVID-19 vaccine BNT162b2 to adults with impaired immune systems, but it was still considering whether a third round of shots should be given to the general public, as reported in Fidelity.
-
Pfizer, U.S. health officials to discuss COVID boosters on Monday
firstwordpharma
July 12, 2021
Pfizer said Sunday that it will meet with representatives of the FDA as soon as Monday to discuss the need for a booster dose of its COVID-19 vaccine as it prepares to seek authorization, as reported in Investing.com.
-
Sanofi, GSK get approval for Phase 3 COVID-19 vaccine trial in India
expresspharma
July 09, 2021
In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus strain (D.614), while a second stage will evaluate a second formulation targeting the Beta variant (B.1.351).
-
Positive new data for Johnson & Johnson single-shot COVID-19 vaccine on activity against Delta variant and long-lasting durability of response
worldpharmanews
July 08, 2021
Johnson & Johnson announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants.
-
Israel reports decrease in Pfizer vaccine effectiveness against infections
expresspharma
July 08, 2021
The decline coincided with the spread of the Delta variant and the end of social distancing restrictions in Israel.
-
Germany to donate all remaining AstraZeneca vaccines in Aug
firstwordpharma
July 08, 2021
Germany will give all its remaining AstraZeneca COVID-19 vaccine doses to less developed countries in August, as reported This is Money on Wednesday.
-
Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate
prnasia
July 06, 2021
Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address the world's most life-threatening diseases and public health threats, today announced the completion of ...
-
Novel COVID-19 vaccine shows promise in Canadian trial
europeanpharmaceuticalreview
July 05, 2021
Phase I data shows VBI-2902a induced neutralisation and antibody titres up to five times that of people who had recovered from COVID-19 infection.
-
Novavax’ COVID-19 vaccine almost 90 percent effective in Phase III trials
europeanpharmaceuticalreview
July 02, 2021
In UK trials where 60 percent of COVID-19 cases were caused by the Alpha SARS-CoV-2 variant, the NVX-CoV2373 COVID-19 vaccine was 89.7 percent effective.